Global Digestive Remedies Market 2018-2022 - Product Image

Global Digestive Remedies Market 2018-2022

  • ID: 4541139
  • Report
  • Region: Global
  • 122 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Bayer Healthcare
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck KGaA
  • Pfizer
  • Sanofi
  • MORE
About Digestive Remedies
Digestive remedies are used for the treatment of gastrointestinal (GI) disorders. The most common digestive disorders are indigestion, heartburn, diarrhoea, irritable bowel syndrome (IBS), motion sickness, paediatric digestive disorders, and constipation.
The analysts forecast the Global Digestive Remedies Market to grow at a CAGR of 4.1% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the digestive remedies market. To calculate the market size, the report considers the revenue generated from the sales of digestive remedies.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, digestive remedies market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Sanofi
  • GlaxoSmithKline
  • Pfizer
  • Bayer Healthcare
  • Johnson & Johnson
  • Merck KGaA
Market drivers
  • Availability of OTC products
Market challenges
  • Threat from counterfeit products
Market trends
  • Alternative products
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer Healthcare
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck KGaA
  • Pfizer
  • Sanofi
  • MORE
PART 01 EXECUTIVE SUMMARY

PART 02 SCOPE OF THE REPORT

PART 03 RESEARCH METHODOLOGY

PART 04 MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05 MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06 FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07 MARKET SEGMENTATION BY APPLICATION
  • Segmentation by application
  • Comparison by application
  • IHR – Market size and forecast 2017-2022
  • Diarrhea remedies – Market size and forecast 2017-2022
  • Others – Market size and forecast 2017-2022
  • Market opportunity by application
PART 08 CUSTOMER LANDSCAPE

PART 09 REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Market opportunity
PART 10 DECISION FRAMEWORK

PART 11 DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12 MARKET TRENDS
  • Alternative products
  • Growing online pharmacy
  • 3D printing drugs
PART 13 VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14 VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Sanofi
  • GlaxoSmithKline
  • Pfizer
  • Bayer Healthcare
  • Johnson & Johnson
  • Merck KGaA
PART 15 APPENDIX
  • List of abbreviations
List of Exhbits
Exhibit 01: Global metabolic disorder treatment market
Exhibit 02: Global metabolic disorder treatment market
Exhibit 03: Market characteristics
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Application – Market share 2017-2022 (%)
Exhibit 19: Comparison by application
Exhibit 20: IHR – Market size and forecast 2017-2022 ($ bn)
Exhibit 21: IHR – Year-over-year growth 2018-2022 (%)
Exhibit 22: Diarrhea remedies – Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Diarrhea remedies – Year-over-year growth 2018-2022 (%)
Exhibit 24: Others - Market size and forecast 2017-2022 ($ bn)
Exhibit 25: Others – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Global – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ bn)

List of Exhbits
Exhibit 01: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 02: Top 3 countries in EMEA
Exhibit 03: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 04: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 05: Top 3 countries in APAC
Exhibit 06: Market opportunity
Exhibit 07: Global population 65+ 2010–2017 (%)
Exhibit 08: Vendor landscape
Exhibit 09: Landscape disruption
Exhibit 10: Vendors covered
Exhibit 11: Vendor classification
Exhibit 12: Market positioning of vendors
Exhibit 13: Sanofi overview
Exhibit 14: Sanofi – Business segments
Exhibit 15: Sanofi – Organizational developments
Exhibit 16: Sanofi – Geographic focus
Exhibit 17: Sanofi – Segment focus
Exhibit 18: Sanofi – Key offerings
Exhibit 19: GlaxoSmithKline overview
Exhibit 20: GlaxoSmithKline – Business segments
Exhibit 21: GlaxoSmithKline – Organizational developments
Exhibit 22: GlaxoSmithKline – Geographic focus
Exhibit 23: GlaxoSmithKline – Segment focus
Exhibit 24: GlaxoSmithKline – Key offerings
Exhibit 25: Pfizer overview
Exhibit 26: Pfizer – Business segments
Exhibit 27: Pfizer – Organizational developments
Exhibit 28: Pfizer – Geographic focus
Exhibit 29: Pfizer – Segment focus
Exhibit 30: Pfizer – Key offerings
Exhibit 31: Bayer Healthcare overview
Exhibit 32: Bayer Healthcare – Business segments
Exhibit 33: Bayer Healthcare – Organizational developments
Exhibit 34: Bayer Healthcare – Geographic focus
Exhibit 35: Bayer Healthcare – Segment focus
Exhibit 36: Bayer Healthcare – Key offerings
Exhibit 37: Johnson & Johnson overview
Exhibit 38: Johnson & Johnson – Business segments
Exhibit 39: Johnson & Johnson – Organizational developments
Exhibit 40: Johnson & Johnson – Geographic focus
Exhibit 41: Johnson & Johnson – Segment focus
Exhibit 42: Johnson & Johnson – Key offerings
Exhibit 43: Merck KGaA overview
Exhibit 44: Merck KGaA – Business segments
Exhibit 45: Merck KGaA – Organizational developments
Exhibit 46: Merck KGaA– Geographic focus
Exhibit 47: Merck KGaA – Segment focus
Exhibit 48: Merck KGaA – Key offerings
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bayer Healthcare
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck KGaA
  • Pfizer
  • Sanofi
  • MORE
New Report Released: – Digestive Remedies Market 2018-2022

The author of the report recognizes the following companies as the key players in the digestive remedies market: Sanofi, GlaxoSmithKline, Pfizer, Bayer Healthcare, Johnson & Johnson, Merck KGaA.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is growing online pharmacy”. Health-related information about disorders and their remedies is readily available on the internet. Also, self-medication has increased due to easy access to the internet as it provides a platform where consumers can interact with healthcare researchers all over the world.

According to the report, one driver influencing this market is the availability of OTC products. OTC products can be purchased from any medical store and consumed without the prescription or consultation of healthcare practitioner. Digestive disorders such as diarrhoea and heartburn that have less complications in their initial stage can be cured without medicines or preferably using OTC products.

Further, the report states that one challenge affecting this market is the threat from counterfeit products. Counterfeit products contain active ingredients in appropriate quantities and are deliberately mislabeled to dupe consumers by portraying them as genuine medicines. These fake medicines pose a threat to public health and can result in treatment failure and even death.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Sanofi
  • GlaxoSmithKline
  • Pfizer
  • Bayer Healthcare
  • Johnson & Johnson
  • Merck KGaA
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll